Guides

• HHS 503A peptide guideSubscribers

  HHS named six peptides it says it won't act against when a 503A pharmacy compounds them under ten conditions. HHS calls it an interim policy and says it "is not binding on HHS or the public." The guide lists the forms HHS names and seven questions for your pharmacy.

• DEA telehealth flexibilities end Dec. 31Subscribers

  From Jan. 1, a prescriber needs an in-person visit or another path in the law to prescribe a controlled drug by telehealth. The checklist sorts your patients by schedule and by the path that still works.

• Cash-pay pricing report (Oct. 21 to 30)Subscribers

  What cash-pay telehealth programs charged over those ten days, from 469 seller price listings.